Regulations.gov document
Guidance for Clinical Investigators, Sponsors, and IRBs; Investigational New Drug…
Other · FDA-2010-D-0503 · posted Sep 10, 2013
Key facts
| Document ID | FDA-2010-D-0503-0076 |
|---|---|
| Title | Guidance for Clinical Investigators, Sponsors, and IRBs; Investigational New Drug Applications (INDs) — Determining Whether Human Research Studies Can Be Conducted Without an IND |
| Document type | Other |
| Subtype | Guidance |
| Agency | FDA |
| Docket | FDA-2010-D-0503 |
| Posted | Sep 10, 2013 |
| Comment period opens | Sep 10, 2013 |
At a glance
- 10–99 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: